MO2-5-6Palbociclib (PAL) + cetuximab (CET) vs CET in patients (pts) with head and neck cancer: Asian subgroup analysisMakoto Tahara,Jin Ching Lin,Assuntina Sacco,Jessica Ley,Peter Oppelt,Qi Shen,Kenneth Kern,Holger Thurm,Shaw Ling Wang,Jean Francois Martini,Justin Hoffman,Bohuslav Melichar,Douglas AdkinsANNALS OF ONCOLOGY(2019)引用 0|浏览65暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要